remdesivir

Canada authorizes first drug treatment for COVID-19

Health Canada has approved a drug treating COVID-19 for the first time ever.

Remdesivir will be authorized for patients of the virus who have pneumonia and require extra oxygen to help them breathe. 

The drug has been approved for use in adults and adolescents aged 12 years and older, according to a press release announcing the news on July 28.

Until now, just a small number of patients in Canada have been treated with remdesivir under the Special Access Program. 

The drug, which is administered through an IV, will be used only in healthcare facilities where patients can be closely monitored.

The treatment has also been granted emergency or conditional authorization in the U.S., Europe, Japan, Singapore and Australia.

In Canada, the authorization included a full scientific review to determine that the drug's benefits outweigh its risks. 

Health Canada will continue to closely monitor the safety of remdesivir and will take prompt action should any safety concerns arise.

Lead photo by

Gilead


Join the conversation Load comments

Latest in News

The Canada-U.S. border could remain closed until next summer

The number of COVID-19 cases in Canada could be higher than previously thought

Man goes on racist tirade at liquor store in Edmonton

New grads in Canada could miss out on $25k in earnings over the next 5 years

Man kicks passenger off bus in Canada for harassing driver

Air Canada earnings take huge fall with revenue down $4.2 billion

CERB is ending soon so Justin Trudeau just revealed what happens next

These major Canadian companies want employees to work from home until 2021